FluidForm Bio specializes in creating living human tissue using advanced bioprinting technology, integrating personalized medicine, synthetic biology, and artificial intelligence. This innovative approach transforms patient data into functional tissues, addressing critical needs in the biotechnology and healthcare sectors.
3D bioprinting technology, Patient-specific organ creation, Viable organ replacement solutions, Utilizing patient's own cells, Addressing organ rejection issues
Regen Network
Kite Pharma
California, • United States
Fibrocell Science
Pennsylvania, • United States
News & Media
Search Terms:
fluidform
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about FluidForm
Where is FluidForm located?
The headquarter of FluidForm is located in Sudbury, Massachusetts, United States
FluidForm belongs to the Biotechnology, Business Services, Healthcare Services industry.
What are the specialties of FluidForm?
FluidForm specializes in Living human tissue fabrication, Bioprinting technology, Personalized medicine integration, Synthetic and computational biology, AI-driven tissue development.
What products and services is FluidForm likely to offer?
FluidForm offers Living Human Tissue, Bioprinting Services, Personalized Medicine Solutions, Synthetic Biology Tools, AI-Driven Tissue Modeling.
Who are the competitors of FluidForm?
Competitors of FluidForm are Organovo, Aspect Biosystems, Tissue Regeneration, Biolife4D, Regen Network, Kite Pharma, Fibrocell Science.
What does FluidForm do?
FluidForm Bio specializes in creating living human tissue using advanced bioprinting technology, integrating personalized medicine, synthetic biology, and artificial intelligence. This innovative approach transforms patient data into functional tissues, addressing critical needs in the biotechnology and healthcare sectors.